1163790-75-7

Upstream product

• 1163790-67-7 4-{(S)-4-tert-butoxycarbonyl-2-[(5-carboxymethoxy-1-phenyl-1H-pyrazole-3-carbonyl)amino]butyryl}piperazine-1-carboxylic acid ethyl ester 
• 1163790-66-6 4-{(S)-2-[(5-benzyloxycarbonylmethoxy-1-phenyl-1H-pyrazole-3-carbonyl)amino]-4-tert-butoxycarbonylbutyryl}piperazine-1-carboxylic acid ethyl ester 
• 1163790-65-5 4-{(S)-4-tert-butoxycarbonyl-2-[(5-hydroxy-1-phenyl-1H-pyrazole-3-carbonyl)-amino]-butyryl}-piperazine-1-carboxylic acid ethyl ester 
• 710335-28-7 4-((S)-2-amino-4-tert-butoxycarbonyl-butyryl)piperazine-1-carboxylic acid ethyl ester 
• 1402596-68-2 C₂₂H₂₇N₅O₇ 
• 1163790-68-8 4-[(S)-2-({5-[2-((S)-2-benzyloxycarbonyl-pyrrolidin-1-yl)-2-oxoethoxy]-1-phenyl-1H-pyrazole-3-carbonyl}amino)-4-tert-butoxycarbonylbutyryl]piperazine-1-carboxylic acid ethyl ester 

Relevant academic research and scientific papers

Identification of high-affinity P2Y12 antagonists based on a phenylpyrazole glutamic acid piperazine backbone

A series of novel, highly potent P2Y12 antagonists as inhibitors of platelet aggregation based on a phenylpyrazole glutamic acid piperazine backbone is described. Exploration of the structural requirements of the substituents by probing the str